BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 23084475)

  • 1. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
    Desai NB; Stein NF; LaQuaglia MP; Alektiar KM; Kushner BH; Modak S; Magnan HM; Goodman K; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e67-72. PubMed ID: 23084475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
    Pinnix CC; Fontanilla HP; Hayes-Jordan A; Subbiah V; Bilton SD; Chang EL; Grosshans DR; McAleer MF; Sulman EP; Woo SY; Anderson P; Green HL; Mahajan A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):317-26. PubMed ID: 22104361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma.
    Casey DL; Wexler LH; LaQuaglia MP; Meyers PA; Wolden SL
    Pediatr Blood Cancer; 2014 Sep; 61(9):1565-9. PubMed ID: 24798662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option.
    Honoré C; Amroun K; Vilcot L; Mir O; Domont J; Terrier P; Le Cesne A; Le Péchoux C; Bonvalot S
    Ann Surg Oncol; 2015 Apr; 22(4):1073-9. PubMed ID: 25300608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor.
    Osborne EM; Briere TM; Hayes-Jordan A; Levy LB; Huh WW; Mahajan A; Anderson P; McAleer MF
    Radiother Oncol; 2016 Apr; 119(1):40-4. PubMed ID: 26527430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy.
    Du XL; Tao J; Sheng XG; Lu CH; Yu H; Wang C; Song QQ; Li QS; Pan CX
    Gynecol Oncol; 2012 Apr; 125(1):151-7. PubMed ID: 22198339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL; Sheng XG; Wang C; Yu H; Song QQ; Pan CX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):925-31. PubMed ID: 24506963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.
    Rochet N; Sterzing F; Jensen AD; Dinkel J; Herfarth KK; Schubert K; Eichbaum MH; Schneeweiss A; Sohn C; Debus J; Harms W
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1382-9. PubMed ID: 19628341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
    Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
    Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
    Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?
    Honoré C; Atallah V; Mir O; Orbach D; Ferron G; LePéchoux C; Delhorme JB; Philippe-Chomette P; Sarnacki S; Msika S; Terrier P; Glehen O; Martelli H; Minard-Colin V; Bertucci F; Blay JY; Bonvalot S; Elias D; LeCesne A; Sargos P;
    PLoS One; 2017; 12(2):e0171639. PubMed ID: 28234908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.